Amneal Pharmaceuticals, Inc. AMRX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s shares (diluted)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported shares (diluted) of 328.9M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s shares (diluted) increased by 1.5% year-over-year, from 324M to 328.9M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s shares (diluted) has grown at a 21.0% compound annual growth rate (CAGR), from 604.3M to 1.3B.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.